Contact us   |  

New therapeutic developments II

New therapeutic developments II

21/12/2020 17:00

Speakers: Rudolf Stadler

Target: Health professionals
Subnetworks: Lymphoid malignancies
Disease Groups: Primary cutaneous lymphoma

Professor Rudolf Stadler is Director of Dermatology at the Johannes Wesling Medical Centre, Minden, Germany. He started his medical career at the Free University of Berlin, Berlin, Germany, under the chairmanship of Professor C.E. Orfanos, in 1988 he was appointed Deputy Director of the Department of Dermatology at the Free University of Berlin, and in 1990 he became Director of the Department of Dermatology at the Medical Centre Minden, Minden, Germany. Since the start of his career, Professor Stadler has been working on the transition of dermatology from morphology and local therapies towards functional understanding of skin physiology and introduction of systemic compounds (e.g. retinoids and interferons). For his accomplishments in this area, he received the Oscar Gans Prize from the German Society of Dermatology in 1988. Professor Stadler is a Past-President of the German Society of Dermatology and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. He was also Deputy Secretary of the organising committee for the 17th World Congress of Dermatology in Berlin.

Professor Stadler's main scientific interest is the development and advancement of dermato-oncology, especially in cutaneous T-cell lymphoma (CTCL). He conducted one of the first randomized trials on interferons in CTCL and has been involved in the development of new therapies in this area including brentuximab vedotin. Since May 1990, Professor Stadler chairs the Department of Dermatology of the Medical Centre Minden, a leading Dermatology Department in Europe, and one of the largest in Germany with 30 000 yearly-specialized outpatient consultations, 3200 dermatology inpatient hospitalizations (60 Dermatology inpatient service beds) and high-level expertise in the diagnosis and therapy of skin disease.

Professor Stadler is member in various international and European dermatological societies. He is author of more than 350 full scientific articles with an h-index of 45.44and produced landmark primary publications in the field of dermato-oncology, e.g. lymphoma, melanoma. Over the past 25 years, he had been invited to be a speaker and/or chair in a significant number of national and international dermatology conferences. In 2017, Professor Stadler was awarded the ILDS Certificate of Appreciation for International Leadership in recognition of outstanding and exemplary contributions to promoting and advancing dermatology at the national and international levels, presented at the Annual Meeting of the German Dermatological Society, 2 - 3 March 2018.

To receive the access link to the Webinar, please register here:

* Fields are required